Please assess the completion status of the following clinical trial:

Trial Title: Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* severe brain injury with coma (Glasgow score \<8)~* Early phase of recovery (spontaneous eye-opening) since at least one month and less than six months~* severe hypertonia of the lower limbs (mean Ashworth score \>= 3) with neurovegetative episodes (at least 10 in 48 hours) and/or decortication after failure of treatment per os (clonidine, beta-blocker, baclofen per os)~* written informed consent (next of kin)~Exclusion Criteria:~* surgical, anesthetic or allergic contraindication to baclofen~* uncontrolled sepsis directly threatening the implanted device~* associated medullary trauma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).